Patent 10017463 was granted and assigned to Brandeis University on July, 2018 by the United States Patent and Trademark Office.
Disclosed are small molecule inhibitors of deubiquitinating enzymes (DUBs), and methods of using them. Certain compounds are selective for particular ubiquitin-specific proteases (USPs).